Moderna shattered Wall Street expectations for the third quarter and aggressively raised its full-year sales growth outlook, propelled by surging momentum across its newer product lines and robust geographic diversification. The milestone financial update underscores a pivotal transition for the biotechnology pioneer as it scales beyond its initial pandemic-era footprint and integrates a broader portfolio […]